Clin2
NCT06645769Possibly a fitNot yet recruiting

Testing phenylbutyrate for blood vessel health in young adults

Diabetes

Treatments studied

Part of Hormones & metabolism clinical trials.

This study tests if a medicine called sodium phenylbutyrate can help blood vessels work better. It may help people with diabetes, and healthy people can join as a comparison group.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
30 people
Ages
18 years to 60 years
Study type
Interventional

Who can take part

  • You are between 18 and 59 years old.
  • You either have diabetes (any type) or you are healthy with no history of diabetes or prediabetes.
  • You are not pregnant or breastfeeding.
  • You do not have high blood pressure and you are not taking certain medications (such as blood vessel relaxers, steroids, haloperidol, or valproic acid).
  • You do not have heart failure, severe kidney problems, liver failure, or swelling due to fluid buildup.
  • You have not used tobacco in the past 6 months and no active alcohol or drug abuse.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05199454Recruiting
Study how “fat-like” particles affect blood vessel function

This study looks at whether tiny fat-based particles (“adiposomes”) can affect how well your blood vessels work, especially in people with diabetes and higher body weight. You may be asked to do moderate exercise and other study procedures after passing safety checks.

Chicago, Illinois
NCT04832009Recruiting· Early Phase 1
Test a way to improve blood vessel function with lifestyle

This early-phase study looks at whether a treatment can help reverse problems in blood vessels caused by high glucose (sugar) and blood fat signals. It may be a fit if you are generally healthy, have normal insulin and sugar levels, and have a stable weight.

Kansas City, Kansas
NCT05593549Recruiting· Early Phase 1
Studying blood vessel damage in type 2 diabetes

This early study looks at how “autophagy” (your body’s cell recycling process) relates to small blood-vessel problems in people with type 2 diabetes. It may help researchers understand mechanisms and possible future treatments, mainly for people who meet specific health and medication criteria.

Milwaukee, Wisconsin
NCT06345443Enrolling by invitation
Nicotinamide riboside for blood vessel health

This trial tests a nutritional supplement (nicotinamide riboside) to see how it affects blood flow in healthy adults. It may help understand how to support vascular health as we age.

Rochester, Minnesota
NCT07602166Not yet recruiting· Phase 2
Study of a new drug for salt-sensitive blood pressure

This study tests whether an investigational drug can reduce blood pressure in people whose blood pressure is sensitive to salt. It aims to see if the drug helps by calming an overactive immune system.

Nashville, Tennessee
NCT06384313Recruiting
Butyrate supplement for preventing diabetes

This study tests if a special type of fat (butyrate) can help prevent diabetes in people who are overweight and have early signs of blood sugar problems. You would take a supplement for several weeks to see if it improves how your body handles sugar.

Maastricht, Limburg

Hear when a new Diabetes trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.